Location: Groton, CT
Responsible for initiating, directing and executing scientific research and/or development strategies with research staff in a biomarker focused flow cytometry lab. This senior level scientist will act as technical expert and scientific lead regarding cellular markers using FACS and cell imaging technologies to address regulated preclinical and clinical translation of biomarkers for establishing proof of mechanism for Pfizer drug candidates. Responsible for oversight… www.nature.com
...Read On
The Wellcome Trust Sanger Institute (WTSI) is a world leader in genomic research and has played a major role in sequencing the human genome and characterising patterns of human sequence variation. Applications are invited for a staff scientist to join the Genetic Epidemiology Group at WTSI. The successful candidate will be involved in the design and analysis of large scale genomic epidemiological studies. The role will involve the development of analytical methods to address newly arising met… www.nature.com
...Read On
Physchem Scientist
Closing Date for Applications: 16th January 2011
Line of Management: Reports to Principal Scientist
Hours of Work: Mon – Fri 9.00am – 5.00pm (1hr lunch time)
Holiday Entitlement: 25 days, plus statutory bank holidays
Salary: Commensurate with experience, plus pension contribution, health scheme etc.
Location:Sheffield (UK)
Company Overview: Simcyp is a fast-growing, research-based company that provides consultancy, knowledge integration tools, algorithms, modeli… www.nature.com
...Read On
So 65 percent of Americans say that Obamacare expands government too much, according to the latest USA Today/Gallup poll. And 64 percent say that Obamacare costs too much. That’s good news for Republicans, many of whom have staked out an outright “repeal” position.
But as a look at the graphic above shows, the picture is a bit more complicated than that. 58 percent of Americans say that the bill does not do enough to curb costs, while 52 percent say that it should have included a public option, and 51 percent say that it doesn’t do enough to regulate the insurance companies.
So the picture we see is of a public that is not averse to government activism, but doesn’t trust Barack Obama & Co. to administer the program. And so now 50 percent of Americans disapprove of the bill and disapprove of Obama. In the words of USA Today reporter Susan Page:
Half call passage of the bill “a bad thing” and 47% “a good thing.” That differs from a one-day USA TODAY poll taken March 22 — a day after the House approved the legislation — in which a 49%-40% plurality called the bill “a good thing.”
“Any one-day poll in the immediate aftermath of a major event is likely to be subject not only to sampling error but also to very short-term effects,” says political scientist Charles Franklin of the University of Wisconsin-Madison. At the time, “the news cycle was dominated by the positive side of the story, and only a little bit by the Republicans’ rebuttal to that.”
There was a strong reaction against the tactics Democratic leaders used to pass the bill. A 53% majority call Democratic methods “an abuse of power;” 40% say they are appropriate.
And when asked about incidents of vandalism and threats that followed the bill’s passage, Americans are more inclined to blame Democratic political tactics than critics’ harsh rhetoric. Forty-nine percent say Democratic tactics are “a major reason” for the incidents, while 46% blame criticism by conservative commentators and 43% the criticism of Republican leaders.
Those last findings are particularly interesting–it seems that people blame the Democrats for divisive tactics, not Republicans.
Was Obamacare An Exercise in Vindicating Big Government? If So… “Obama Should Focus on HEALTH, Not ‘Health Care Policy’” While Washington Dithers, Tony Judt Confronts Nightfall When the Best and the Brightest Fail — Call Them “Ivy League Brownies.” Bernanke Confirmation Fallout: Death of the “Med Fed” Idea
www.treatmentofcancer.org
Field Development Scientist - Pest Management
A leading agrochemical company are currently seeking for a Field based scientist with experience in invertebrate pest field trial planning.
Reporting to the Development Manager your duties will include:
·Being responsible for conducting field trials and testing in both crop and food production environments.
·Involved in the continually development of the companies technologies.
·In constant liaison wit www.nature.com
...Read On
You can link to this article on your web site using following code:
Website Code:
Forum Code:
Comments
We're looking for comments that are interesting, substantial or highly amusing. If your comments are excessively self-promotional (use your real name, no keywords please), obnoxious, or even worse, boring, you will be banned from commenting. Your comment must be related to the post. Please do not comment on how great or wonderful the post is. All comments are moderated and, if approved, will display in less than 24 hours.
